[The conservative therapy of urolithiasis (author's transl)].
Some common conservative treating methods of urolithiasis are critically discussed. Based on physico-chemical relationships of solubility and cristallisation of stone-forming compounds our own methods of conservative treatment of urolithiasis is presented.
D000493:Allopurinol / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D003553:Cystine / Q000378:metabolism; D006801:Humans; D007474:Ion Exchange; D008274:Magnesium / Q000378:metabolism / Q000627:therapeutic use; D010070:Oxalates / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D011736:Pyridoxine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D013388:Succinimides / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism; D014545:Urinary Calculi / Q000188:drug therapy* / Q000378:metabolism / Q000652:urine
D010070:Oxalates; D010710:Phosphates; D000644:Quaternary Ammonium Compounds; D013388:Succinimides; D014527:Uric Acid; D003553:Cystine; D000536:Aluminum Hydroxide; D000493:Allopurinol; D008274:Magnesium; D011736:Pyridoxine; D002118:Calcium
Zur konservativen Therapie des Harnsteinleidens.